BIO-key Intl Q4 EPS $(0.19) Misses $(0.07) Estimate, Sales $1.241M Miss $2.200M Estimate

BIO-key International (NASDAQ: BKYI) reported a Q4 loss of $(0.19) per share, missing the analyst estimate of $(0.07) by 171.43%. This represents an increase in losses compared to $(0.46) per share from the same period last year. The company's quarterly sales were $1.241 million, falling short of the $2.200 million estimate by 43.59% and showing a 15.13% decrease from $1.462 million in the prior year.